STAT Plus: Breast cancer pill from AstraZeneca misses mark in pivotal trial
The drug, approved for select patients as Etcamah, failed in a study in advanced tumors. It's being tested in early cancers as well.
Open original source
The drug, approved for select patients as Etcamah, failed in a study in advanced tumors. It's being tested in early cancers as well.
Open original sourceComments stay attached to this story.
Start a connected post from this article without changing the original story.
Creators building their communities through the SpiderTaz Creator Program.
No comments yet.